Blog

RNA Foundation Models to Improve Pharma R&D Productivity

September 2, 2024

As RNA biology and RNA therapeutics emerge in the mainstream of pharma, RNA foundation models offer massive potential for revolutionizing R&D.


First published on MedCity News on September 4, 2024

RNA Foundation Models to Improve Pharma R&D Productivity

As RNA biology and RNA therapeutics emerge in the mainstream of pharma, RNA foundation models offer massive potential for revolutionizing R&D.

By Brendan Frey, Chief Innovation Officer and ...

Why Pharma Must Embrace AI and Open Source

August 27, 2024


First published on Medicine Maker on August 27, 2024

Why Pharma Must Embrace AI and Open Source

With open minds and open sources, the future is foundational – and bright.

By Brendan Frey, Chief Innovation Officer and Co-founder of Deep Genomics 

The cost of bringing new ...

The Deep Genomics AI workbench in action: from understanding disease mechanism to programming an RNA therapeutic

July 22, 2021


Daniele Merico, Head of Target Identification

In early 2017, Deep Genomics developed a software system, called TargetRanch, to identify disease-causing genetic variants that can be remediated by therapeutic oligonucleotides (short stretches of chemically-modified DNA or RNA that attach to a specific place in the RNA ...